AR035813A1 - Indolinonas sustituidas en posicion 6, su preparacion y su utilizacion como medicamentos - Google Patents

Indolinonas sustituidas en posicion 6, su preparacion y su utilizacion como medicamentos

Info

Publication number
AR035813A1
AR035813A1 ARP020101257A ARP020101257A AR035813A1 AR 035813 A1 AR035813 A1 AR 035813A1 AR P020101257 A ARP020101257 A AR P020101257A AR P020101257 A ARP020101257 A AR P020101257A AR 035813 A1 AR035813 A1 AR 035813A1
Authority
AR
Argentina
Prior art keywords
alkyl
group
amino
phenyl
carbonyl
Prior art date
Application number
ARP020101257A
Other languages
English (en)
Spanish (es)
Inventor
Roth Gerald Jurgen Dr
Heckel Armin Dr
Kley Jorg Dr
Hilberg Frank Dr
Van Meel Jacobus Dr
Lehmann-Lintz Thorsten Dr
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of AR035813A1 publication Critical patent/AR035813A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
ARP020101257A 2001-04-06 2002-04-05 Indolinonas sustituidas en posicion 6, su preparacion y su utilizacion como medicamentos AR035813A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10117204A DE10117204A1 (de) 2001-04-06 2001-04-06 In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
AR035813A1 true AR035813A1 (es) 2004-07-14

Family

ID=7680648

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101257A AR035813A1 (es) 2001-04-06 2002-04-05 Indolinonas sustituidas en posicion 6, su preparacion y su utilizacion como medicamentos

Country Status (23)

Country Link
US (1) US6858641B2 (https=)
EP (1) EP1379501A1 (https=)
JP (1) JP2004525173A (https=)
KR (1) KR20030090712A (https=)
CN (1) CN1509270A (https=)
AR (1) AR035813A1 (https=)
BG (1) BG108220A (https=)
BR (1) BR0208900A (https=)
CA (1) CA2442695A1 (https=)
CZ (1) CZ20032975A3 (https=)
DE (1) DE10117204A1 (https=)
EA (1) EA200301005A1 (https=)
EC (1) ECSP034776A (https=)
EE (1) EE200300491A (https=)
HU (1) HUP0303737A3 (https=)
IL (1) IL158254A0 (https=)
MX (1) MXPA03008896A (https=)
NO (1) NO20034434D0 (https=)
PE (1) PE20021058A1 (https=)
PL (1) PL366458A1 (https=)
SK (1) SK12412003A3 (https=)
WO (1) WO2002081445A1 (https=)
ZA (1) ZA200307306B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10233500A1 (de) 2002-07-24 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
JP4879492B2 (ja) * 2002-11-27 2012-02-22 アラーガン、インコーポレイテッド 疾患の治療のためのキナーゼ阻害剤
PE20061155A1 (es) * 2004-12-24 2006-12-16 Boehringer Ingelheim Int Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
US20060154939A1 (en) * 2004-12-24 2006-07-13 Boehringer Ingelheim International Gmbh Medicaments for the Treatment or Prevention of Fibrotic Diseases
WO2007057397A1 (en) * 2005-11-15 2007-05-24 Boehringer Ingelheim International Gmbh Treatment of cancer
AU2008309517B2 (en) 2007-10-12 2013-03-14 Astrazeneca Ab Inhibitors of protein kinases
UY31506A1 (es) * 2007-12-03 2009-08-03 Derivados de indolinona y procedimiento para su preparacion
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
WO2010009166A1 (en) * 2008-07-14 2010-01-21 Gilead Colorado, Inc. Oxindolyl inhibitor compounds
NZ590560A (en) 2008-07-29 2012-12-21 Boehringer Ingelheim Int Indolinone Inhibitors of cell cycle kinases
CA2789189A1 (en) 2010-03-10 2011-09-15 Ingenium Pharmaceuticals Gmbh Inhibitors of protein kinases
CN102267934B (zh) * 2010-06-02 2013-04-17 金凯美(大连)医药科技有限公司 一种6-甲氧羰基吲哚酮的制备方法
PL3722291T3 (pl) 2015-12-24 2023-11-27 Respivert Limited Związki indolinonowe i ich zastosowanie w leczeniu chorób zwłóknieniowych
CN109153666B (zh) * 2016-03-08 2021-07-16 莱斯彼维特有限公司 吲哚衍生物及其作为蛋白激酶抑制剂的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998007695A1 (en) * 1996-08-23 1998-02-26 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
US6043254A (en) 1998-04-03 2000-03-28 Boehringer Ingelheim Pharma Kg Indolinones having kinase-inhibiting activity
DE19816624A1 (de) 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US6169106B1 (en) 1998-04-15 2001-01-02 Boehringer Ingelheim Pharma Kg Indolinones having kinase inhibitory activity
DE19824922A1 (de) * 1998-06-04 1999-12-09 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US6319918B1 (en) * 1998-06-04 2001-11-20 Boehringer Ingelheim Pharma Kg Substituted indolinones with kinase inhibitory activity
DE19924401A1 (de) 1999-05-27 2000-11-30 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DE19940829A1 (de) 1999-08-27 2001-03-01 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
CA2381821A1 (en) 1999-08-27 2001-03-08 Boehringer Ingelheim Pharma Kg Substituted indolinones, their manufacture and their use as medicaments
DE10042696A1 (de) 2000-08-31 2002-03-14 Boehringer Ingelheim Pharma In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
UA75054C2 (uk) 1999-10-13 2006-03-15 Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу

Also Published As

Publication number Publication date
HUP0303737A3 (en) 2004-09-28
IL158254A0 (en) 2004-05-12
HUP0303737A2 (hu) 2004-03-01
CA2442695A1 (en) 2002-10-17
DE10117204A1 (de) 2002-10-10
EE200300491A (et) 2004-02-16
JP2004525173A (ja) 2004-08-19
EA200301005A1 (ru) 2004-04-29
BR0208900A (pt) 2004-04-20
CN1509270A (zh) 2004-06-30
SK12412003A3 (sk) 2004-04-06
BG108220A (bg) 2004-09-30
CZ20032975A3 (cs) 2004-02-18
NO20034434L (no) 2003-10-03
PE20021058A1 (es) 2003-01-20
US6858641B2 (en) 2005-02-22
ZA200307306B (en) 2004-08-31
WO2002081445A1 (de) 2002-10-17
NO20034434D0 (no) 2003-10-03
PL366458A1 (en) 2005-02-07
KR20030090712A (ko) 2003-11-28
US20030092756A1 (en) 2003-05-15
MXPA03008896A (es) 2003-12-08
ECSP034776A (es) 2003-12-01
EP1379501A1 (de) 2004-01-14

Similar Documents

Publication Publication Date Title
AR035813A1 (es) Indolinonas sustituidas en posicion 6, su preparacion y su utilizacion como medicamentos
EA200300523A1 (ru) Ингибиторы трипептидил пептидазы
EA200870192A1 (ru) Новые серосодержащие производные циклической мочевины, их получение и их фармацевтическое применение в качестве ингибиторов киназ
AR017182A1 (es) Compuestos de aminotiazol, inhibidores de las kinasas dependientes de ciclinas y las composiciones farmaceuticas que los contienen.
AR037485A1 (es) Uso de un compuesto derivado de pirazol-triazina en la fabricacion de un medicamento, medicamento que comprende un compuesto derivado de pirazol-triazina, producto industrial y composicion farmaceutica
EA200700192A1 (ru) Производные фталазина в качестве ингибиторов parp
ATE453639T1 (de) Phenylsubstituierte pyrimidinverbindungen zur verwendung als kinasehemmer
HUP0301249A2 (hu) APO B termelődés gátló benzamid-vegyületek ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AR042024A1 (es) Compuestos farmaceuticos derivados de piridona, pirimidona y pirazinona
AR059086A1 (es) Derivados de urea ciclica su preparcion y su utilizacion farmaceutica como inhibidores de cinasas
AR050261A2 (es) Aminoacidos con afinidad por la proteina alfa-2-delta y composiciones farmaceuticas que los contienen y su uso para preparar un medicamento
AR042275A1 (es) Imidazo- piridinosas sustituidas, su preparacion y su empleo como medicamentos
AR045595A1 (es) Composiciones utiles como inhibidores de proteinas quinasas
AR030230A1 (es) Derivados de acilfenilurea, procedimiento para su preparacion y su empleo en la preparacion de medicamentos
AR047898A1 (es) Benzamidas sustituidas,metodos de preparacion,composiciones farmaceuticas que las contienen y usos
ECSP034865A (es) Resolución óptica de (1-benzilo-4-metilopiperidina-3-il)-metilamina y su uso para la preparación de derivados de pirrolo 2,3-pirimidina como inhibidores de proteina quinasas
CO5680403A2 (es) Antagonistas de mchr1r
AR042659A1 (es) Derivados de 4-5 diariltiazoles como ligandos de cb-1
PA8603801A1 (es) Derivados de la quinazolina
HUP0401784A2 (hu) Heterobiciklikus szerkezetû virális polimeráz inhibitorok, eljárás az elõállításukra, köztitermékek és ezeket tartalmazó gyógyszerkészítmények
AR062406A1 (es) Derivados de quinazolina como inhibidores de b-raf
ES2255190T3 (es) Compuestos indol 2,3-sustituidos como inhibidores de cox-2.
AR057380A1 (es) Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
AR041697A1 (es) Piperazinil y diazepanil benzamidas y benzotiamidas; composiciones farmaceuticas que las contienen y su uso para la fabricacion de un medicamento
AR061835A1 (es) Derivados tetraciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen

Legal Events

Date Code Title Description
FA Abandonment or withdrawal